Study on the Effects of DA-9701 on Gastrointestinal Motility on Healthy Adult Volunteers

Inclusion Criteria: * Healthy adults of either sex, at least 20 years of age * Having no abdominal discomfort or pain * No diseases diagnosed by screening gastroduodenoscopy * Having given voluntary written consent Exclusion Criteria: * Currently participating or having participated in another drug trial within four weeks of trial start. * Women of childbearing age who are either pregnant, breast-feeding or not under proper contraceptive methods. * A history of surgery which may affect gastrointestinal motility. * Subjects with gastrointestinal bleeding, mechanical obstruction or perforation. * Subjects with irritable bowel syndrome or inflammatory bowel disease. * Subjects with serious conditions involving the liver, kidneys, heart, lung or endocrinology system. * Psychiatric disease patients, substance abuse subjects such as alcohol or drugs. * Subjects who have taken drugs that may affect the study outcome such as antibiotics, corticosteroids or NSAIDS within 1 month or motility agents, H2 receptor blockers, proton pump inhibitors, anticholinergics, erythromycin or antipsychotics within 2 weeks. * Other reasons that the investigator considers valid.